# Solitario Resources Corp.: financial statements, quarterly

XPL · NYSE · CIK 917225 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xpl.md) · [Financials](/companies/xpl/financials.md) · [Filings](/companies/xpl/filings.md) · [Insiders](/companies/xpl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xpl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,292)](/filings/0001654954-24-013703.md) | [(1,042) d](/filings/0001654954-25-002628.md) | [(730)](/filings/0001654954-25-012378.md) | [(762)](/filings/0001654954-25-012378.md) | [(2,276)](/filings/0001654954-25-012378.md) | [(1,600) d](/filings/0001654954-26-002156.md) | [(511)](/filings/0001654954-26-007347.md) | [(943)](/filings/0001654954-26-007347.md) | [(1,870)](/filings/0001654954-25-012378.md) | [(509) d](/filings/0001654954-26-002156.md) | [(494)](/filings/0001654954-26-007347.md) | [(1,830)](/filings/0001654954-26-007347.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.01)](/filings/0001654954-25-005017.md) | [(0.01)](/filings/0001654954-25-009100.md) | [(0.03)](/filings/0001654954-25-012378.md) | not reported | [(0.01)](/filings/0001654954-26-004400.md) | [(0.01)](/filings/0001654954-26-007347.md) | [(0.02)](/filings/0001654954-25-012378.md) | not reported | [(0.01)](/filings/0001654954-26-004400.md) | [(0.02)](/filings/0001654954-26-007347.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001654954-24-013703.md) | not reported | not reported | not reported | [(0.03)](/filings/0001654954-24-013703.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: not reported
- Operating income: not reported
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.2](/filings/0001654954-25-002628.md) | not reported | [0.2](/filings/0001654954-24-009611.md) | [0.1](/filings/0001654954-24-013703.md) | [0.1](/filings/0001654954-26-002156.md) | not reported | not reported | [0.3](/filings/0001654954-25-012378.md) | [0.1](/filings/0001654954-26-007347.md) | [0.2](/filings/0001654954-26-004400.md) | [0.5](/filings/0001654954-26-007347.md) |
| Current assets | $m | [5.3](/filings/0001654954-23-013940.md) | [9.9](/filings/0001654954-25-002628.md) | [8.9](/filings/0001654954-24-005410.md) | [9.7](/filings/0001654954-24-009611.md) | [8.0](/filings/0001654954-24-013703.md) | [6.0](/filings/0001654954-26-002156.md) | [5.9](/filings/0001654954-25-005017.md) | [9.6](/filings/0001654954-25-009100.md) | [8.4](/filings/0001654954-25-012378.md) | [8.0](/filings/0001654954-26-007347.md) | [8.9](/filings/0001654954-26-004400.md) | [9.2](/filings/0001654954-26-007347.md) |
| Total assets | $m | [22.1](/filings/0001654954-23-013940.md) | [26.8](/filings/0001654954-25-002628.md) | [25.7](/filings/0001654954-24-005410.md) | [26.6](/filings/0001654954-24-009611.md) | [24.9](/filings/0001654954-24-013703.md) | [23.0](/filings/0001654954-26-002156.md) | [23.0](/filings/0001654954-25-005017.md) | [26.7](/filings/0001654954-25-009100.md) | [25.4](/filings/0001654954-25-012378.md) | [25.0](/filings/0001654954-26-007347.md) | [25.9](/filings/0001654954-26-004400.md) | [26.2](/filings/0001654954-26-007347.md) |
| Current liabilities | $m | [0.3](/filings/0001654954-23-013940.md) | [0.6](/filings/0001654954-25-002628.md) | [0.2](/filings/0001654954-24-005410.md) | [0.4](/filings/0001654954-24-009611.md) | [0.8](/filings/0001654954-24-013703.md) | [0.4](/filings/0001654954-26-002156.md) | [0.5](/filings/0001654954-25-005017.md) | [0.5](/filings/0001654954-25-009100.md) | [0.5](/filings/0001654954-25-012378.md) | [0.2](/filings/0001654954-26-007347.md) | [0.3](/filings/0001654954-26-004400.md) | [0.7](/filings/0001654954-26-007347.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [21.6](/filings/0001654954-24-013703.md) | [26.0](/filings/0001654954-26-002156.md) | [25.3](/filings/0001654954-25-012378.md) | [26.1](/filings/0001654954-25-012378.md) | [24.0](/filings/0001654954-25-012378.md) | [22.5](/filings/0001654954-26-007347.md) | [22.3](/filings/0001654954-26-007347.md) | [26.0](/filings/0001654954-26-007347.md) | [24.7](/filings/0001654954-25-012378.md) | [24.7](/filings/0001654954-26-007347.md) | [25.4](/filings/0001654954-26-007347.md) | [25.4](/filings/0001654954-26-007347.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(919) d](/filings/0001654954-24-013703.md) | [(579) d](/filings/0001654954-25-002628.md) | [(991)](/filings/0001654954-25-005017.md) | [(579) d](/filings/0001654954-25-009100.md) | [(1,780) d](/filings/0001654954-25-012378.md) | [(1,749) d](/filings/0001654954-26-002156.md) | [(598)](/filings/0001654954-26-004400.md) | [(803) d](/filings/0001654954-26-007347.md) | [(1,663) d](/filings/0001654954-25-012378.md) | [(506) d](/filings/0001654954-26-002156.md) | [(473)](/filings/0001654954-26-004400.md) | [(1,375) d](/filings/0001654954-26-007347.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2019 (2019-06-30) | Q2 FY2020 (2020-06-30) | Q2 FY2021 (2021-06-30) | Q4 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.1](/filings/0001654954-20-008082.md) | [0.1](/filings/0001654954-21-008519.md) | [0.1](/filings/0001654954-21-008519.md) | [79.6](/filings/0001654954-25-005017.md) | [81.1](/filings/0001654954-25-009100.md) | [0.1](/filings/0001654954-25-012378.md) | [81.7](/filings/0001654954-26-004400.md) | [84.1](/filings/0001654954-26-007347.md) | [0.1](/filings/0001654954-25-012378.md) | [91.7](/filings/0001654954-26-004400.md) | [93.7](/filings/0001654954-26-007347.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 94,684,463 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001654954-26-007347.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.